Mission Bio

San Francisco, CA · Founded 2011 · Privately Held (backing)

Developer of a precision genomics platform designed to provide single-cell targeted DNA sequencing at single-base resolution. Mission Bio is based in San Francisco, CA and was founded in 2011. It was valued at $300 million at its later-stage round in May 2022, the last priced event on record. It has raised $212 million across 2 recorded rounds; the latest was a $28.4 million early-stage round in Jun 2018.

PMV mark · valuation
$300.0M
Oct 2026
Priced at
its later-stage round
May 2022
Total raised
$212.1M
Last round
Early Stage VC
Jun 2018
What is Mission Bio worth?
$300.0MPrivateMarketView mark · Oct 2026

Valued at $300.0M at its later-stage round, May 2022. Nothing has traded since.

Free account
More of Mission Bio with a free account
  • ·The complete investor list: 41 names
  • ·Watch Mission Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Mission Bio funding history

2 rounds
DateRoundRaisedPost-money
Jun 2018Early Stage VC$28.4M▮
Jun 2017Early Stage VC$13.3M▮
Unlock post-money valuations

Membership and data by Private Market View

Mission Bio valuation

Mission Bio was valued at $300 million at its later-stage round in May 2022. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Mission Bio raised?

Mission Bio has raised $212 million in total; 2 of its rounds are on record. The largest on record was a $28.4 million early-stage round in Jun 2018.

Mission Bio has filed 2 Form Ds with the SEC since 2017, most recently in Jul 2018 ($28.4 million sold to 32 investors).

How Mission Bio's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Mission Bio, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Mission Bio

What is Mission Bio worth?
Mission Bio is valued at $300.0M as of Oct 2026. Valued at $300.0M at its later-stage round, May 2022. Nothing has traded since.
How much has Mission Bio raised?
Mission Bio has raised $212.1M in total funding across 2 recorded rounds.
When did Mission Bio last raise?
Mission Bio last raised in Jun 2018 (Early Stage VC), raising $28.4M.